124 related articles for article (PubMed ID: 9521273)
1. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis.
Torres-Aleman I; Barrios V; Berciano J
Neurology; 1998 Mar; 50(3):772-6. PubMed ID: 9521273
[TBL] [Abstract][Full Text] [Related]
2. Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.
Hosback S; Hardiman O; Nolan CM; Doyle MA; Gorman G; Lynch C; O'Toole O; Jakeman P
Growth Horm IGF Res; 2007 Dec; 17(6):472-9. PubMed ID: 17697791
[TBL] [Abstract][Full Text] [Related]
3. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Corbo M; Lunetta C; Magni P; Dozio E; Ruscica M; Adobbati L; Silani V
Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
[TBL] [Abstract][Full Text] [Related]
4. Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.
Wilczak N; de Vos RA; De Keyser J
Lancet; 2003 Mar; 361(9362):1007-11. PubMed ID: 12660059
[TBL] [Abstract][Full Text] [Related]
5. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.
Pellecchia MT; Pivonello R; Monsurrò MR; Trojsi F; Longo K; Piccirillo G; Pivonello C; Rocco M; Di Somma C; Colao A; Tedeschi G; Barone P
Eur J Neurol; 2010 May; 17(5):666-71. PubMed ID: 20002733
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis.
Braunstein GD; Reviczky AL
J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):792-4. PubMed ID: 3302111
[TBL] [Abstract][Full Text] [Related]
7. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.
Doré S; Krieger C; Kar S; Quirion R
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):128-33. PubMed ID: 8883943
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor system in amyotrophic lateral sclerosis.
Wilczak N; Keyser J
Endocr Dev; 2005; 9():160-169. PubMed ID: 15879696
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis.
Rauskolb S; Dombert B; Sendtner M
Neurobiol Dis; 2017 Jan; 97(Pt B):103-113. PubMed ID: 27142684
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic and Neuroregenerative Effects of GH/IGF1.
Bianchi VE; Locatelli V; Rizzi L
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149058
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
Mitchell JD; Wokke JH; Borasio GD
Cochrane Database Syst Rev; 2002; (3):CD002064. PubMed ID: 12137643
[TBL] [Abstract][Full Text] [Related]
12. Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients.
Lunetta C; Serafini M; Prelle A; Magni P; Dozio E; Ruscica M; Sassone J; Colciago C; Moggio M; Corbo M; Silani V
Muscle Nerve; 2012 Feb; 45(2):200-8. PubMed ID: 22246875
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
Lewis ME; Neff NT; Contreras PC; Stong DB; Oppenheim RW; Grebow PE; Vaught JL
Exp Neurol; 1993 Nov; 124(1):73-88. PubMed ID: 8282084
[TBL] [Abstract][Full Text] [Related]
14. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients.
Kihira T; Suzuki A; Kondo T; Wakayama I; Yoshida S; Hasegawa K; Garruto RM
Neuropathology; 2009 Oct; 29(5):548-58. PubMed ID: 19323791
[TBL] [Abstract][Full Text] [Related]
16. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature.
Rooman RP; De Beeck LO; Martin M; van Doorn J; Mohan S; Du Caju MV
Eur J Endocrinol; 2005 Apr; 152(4):597-604. PubMed ID: 15817916
[TBL] [Abstract][Full Text] [Related]
17. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
18. Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.
Steyn FJ; Ngo ST; Lee JD; Leong JW; Buckley AJ; Veldhuis JD; McCombe PA; Chen C; Bellingham MC
Endocrinology; 2012 Aug; 153(8):3735-46. PubMed ID: 22621959
[TBL] [Abstract][Full Text] [Related]
19. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis.
Ono S; Hu J; Imai T; Shimizu N; Tsumura M; Nakagawa H
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):199-203. PubMed ID: 10896693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
